STING1 and cancer: With the recent recognition of a critical role for cytosolic DNA sensors’ inflammasomes in stimulating antitumor immunity, the search for and development of pharmaceutical agonists of STING and AIM2 have been an active area of investigation in cancer immunotherapy (71).